Latest Drugs, Latest Approval in Neuraminidase inhibitors

What are Neuraminidase inhibitors?

Neuraminidase inhibitors are drugs that block the function of the viral neuraminidase protein. By blocking this protein enzyme it stops the release of viruses from the infected host cell and prevents new host cells from being infected. These antiviral agents inhibit all subtypes of neuraminidase enzymes, therefore are effective against influenza viruses A and B.

Name Updated
Peramivir (Peramivir [ per-am-i-vir ]) 15-Aug-2023
Zanamivir (Zanamivir [ zan-am-i-vir ]) 12-Aug-2023
Oseltamivir (Oseltamivir [ os-el-tam-ih-veer ]) 11-Aug-2023
Relenza (Zanamivir [ zan-am-i-vir ]) 14-Jul-2023
Rapivab (Peramivir [ per-am-i-vir ]) 14-Jul-2023
Tamiflu (Oseltamivir [ os-el-tam-ih-veer ]) 12-Jul-2023